SCHEMBL26133752

SCHEMBL26133752

CN1CCN(Cc2ccc(N)cc2F)CC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.45
PIK3CD O00329 1/20 0.41
DPP4 P27487 1/20 0.40
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 2/20 0.37
COMT P21964 1/20 0.37
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
ADRA2B P18089 1/20 0.36
EPHX2 P34913 1/20 0.36
ACHE P22303 2/20 0.35
DRD2 P14416 1/20 0.35
MAOA P21397 1/20 0.35
LMNA P02545 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90B1 P14625 1/20 0.34
TRAP1 Q12931 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3398174 0.82 MAPK1 (0.56) NR1H2PIK3CDCOMTMAPK1KMT2A
SCHEMBL15542251 0.80 NR1H2 (0.67) NR1H2KDM4ESMN1; SMN2ALDH1A1ACHE
SCHEMBL23747510 0.80 ALDH1A1 (0.42) PIK3CDKDM4ESMN1; SMN2ALDH1A1KMT2A
SCHEMBL3401709 0.77 LMNA (0.60) PIK3CDALDH1A1TLR7LMNA
SCHEMBL30309475 0.77 NR1H2 (0.51) NR1H2KDM4ESMN1; SMN2ALDH1A1KMT2A
SCHEMBL15688210 0.77 NR1H2 (0.51) NR1H2KDM4ESMN1; SMN2ALDH1A1KMT2A
SCHEMBL26134101 0.76 MAPK1 (0.45) NR1H2DPP4MAPK1KMT2AADRA2B
SCHEMBL26133559 0.76 TLR7 (0.42) PIK3CDDPP4ALDH1A1TLR7LMNA
SCHEMBL13495620 0.75 SMN1; SMN2 (0.67) NR1H2KDM4ESMN1; SMN2ALDH1A1ADRA2B
SCHEMBL16620680 0.75 KDM4E (0.62) NR1H2KDM4ESMN1; SMN2ALDH1A1ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 NR1H2 509/4885PIK3CD 3016/4885DPP4 2782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.